Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93263281 | 9326328 | 1 | I | 20120723 | 0 | 20121005 | 20121005 | DIR | 66.00 | YR | M | N | 170.00000 | LBS | 20120924 | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93263281 | 9326328 | 1 | PS | IMIQUIMOD CREAM (TOLMAR INC.)-RLD ZYCLARA | 1 | TOPICAL | N | N | 0 | ||||||||||
| 93263281 | 9326328 | 3 | C | LISINOPRIL | 1 | 0 | |||||||||||||
| 93263281 | 9326328 | 5 | C | CELEBREX | 1 | 0 | |||||||||||||
| 93263281 | 9326328 | 7 | C | BABY ASPIRIN | 1 | 0 | |||||||||||||
| 93263281 | 9326328 | 9 | C | MUTIVITAMIN | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93263281 | 9326328 | 1 | Actinic keratosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93263281 | 9326328 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93263281 | 9326328 | Cerebrovascular accident | |
| 93263281 | 9326328 | Nervous system disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93263281 | 9326328 | 1 | 20120619 | 20120722 | 0 |